International Isotopes (INIS)

Overall impact
C (55)

Commentary

International Isotopes is an average overall performer. With a 'C' rating of 54.6 for overall impact (51st percentile compared to all companies), International Isotopes ranks 17th out of 47 industry peers, behind Mechanical Technology, Flexpoint Sensor Systems, Hexagon and 13 others, and ahead of Schmitt Industries, Giga Tronics, Cyberoptics and 27 others. On top material causes for International Isotopes's industry (Technology Hardware), International Isotopes performs well in Conflict Free Mineral Production (82.0 score) and performs poorly in Quality Lifelong Education (34.2 score), Technology Innovation (18.0), Reduced Green House Gas Emissions (29.5) and 1 other cause where it received a 'D' or 'F' score.
Impact
Cause INIS
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
44
Sector
Information Technology
Industry
Electronic Equipment, Instruments & Components
Sub-industry
Electronic Equipment & Instruments
SASB industry
Medical Equipment & Supplies
Headquarters
Id, United States
Share classes
INIS
Description
International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, sodium iodide I-131 drug product, and radiochemicals for clinical research and life sciences in the United States and internationally. It operates through five segments: Theranostics Products, Cobalt Products, Nuclear Medicine Standards, Medical Devices, and Fluorine Products. The Theranostics Products segment produces and distributes Iodine-131 generic drug product and various isotopically pure radiochemicals for medical, industrial, or research applications. The Cobalt Products segment produces cobalt-60 products and services, the fabrication of cobalt-60 sealed sources for radiation therapy, industrial and medical applications, and recycling of expended cobalt-60 sources. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. This segment also offers flood sources, dose calibrators, cylinder phantoms, rod sources, line sources, flexible and rigid rulers, spot markers, pen point markers, and various specialty design items. The Medical Devices segment develops the EasyFill Automated Capsule System, a robotic lab device. The Fluorine Products segment is involved in the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as the development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. The company sells its products directly to end users and distributors. International Isotopes Inc. was incorporated in 1995 and is headquartered in Idaho Falls, Idaho.
Material causes
Ethos considers the following causes material for International Isotopes, based on its industry sub-industry Electronic Equipment & Instruments. Learn more about material causes in our methodology overview.
Not available

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.